| [1] |
韩选伟, 胡同平, 张文兰. 10681例输血前、术前、产前患者感染性疾病标志物检查结果分析[J]. 中国医学创新, 2012, 9(5):71–72.
|
| [2] |
王斌, 张录喜, 李红, 刘瑞红, 等. 12870例术前和输血前四项传染病指标检测结果及意义[J]. 当代医学, 2012, 18(11):18–19.
|
| [3] |
王海滨, 石新慧. 输血前四项感染指标联合测定的结果分析[J]. 中华实验和临床感染病杂志(电子版), 2013, 7(2):269–271.
|
| [4] |
王友新, 钟瑜, 黄玉香. 输血前四项感染性指标检测的临床价值[J]. 临床和实验医学杂志, 2011, 10(5):373.
|
| [5] |
杨慧. 受血者输血前四项传染性指标检测3216例分析[J]. 上海预防医学, 2010, 22(4):190–191.
|
| [6] |
吴来林. 5783例创伤患者手术前4项血液传染病指标检测情况分析[J]. 浙江创伤外科, 2014, 19(6):996–997.
|
| [7] |
林甲进, 朱碎永, 张瑛. 患者输血前血液传播性疾病检测意义的探讨[J]. 中华医院感染学杂志, 2001, 11(5):365,397.
|
| [8] |
叶贤林, 柏景乔. 无偿献血人群低水平乙肝感染情况调查分析[J]. 中国预防医学杂志, 2007, 8(3):183–185.
|
| [9] |
La’ulu SL, Roberts WL. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays[J]. Am J Clin Pathol, 2006, 125(5):748–751.
|
| [10] |
Moerman B, Moons V, Sommer H, et al. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays[J]. Clin Lab, 2004, 50(3–4):159–162.
|
| [11] |
Scheiblauer H, Soboll H, Nick S. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection[J]. J Med Virol, 2006, 78 Suppl 1:S66–70.
|
| [12] |
Sommese L, Sabia C, Paolillo R, et al. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems[J]. Scand J Infect Dis, 2014, 46(9):660–664.
|
| [13] |
Verheyen J, Neumann-Fraune M, Berg T, et al. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays[J]. J Clin Virol, 2012, 54(3):279–281.
|
| [14] |
田拥军, 覃莉, 刘慎沛, 等. 8种国产HBsAg试剂盒检测变异HBsAg的效果评价[J]. 临床检验杂志, 2007, 25(4):250–252.
|
| [15] |
Peng J, Cheng L, Yin B, et al. Development of an economic and efficient strategy to detect HBsAg: application of "gray-zones" in ELISA and combined use of several detection assays[J]. Clin Chim Acta, 2011, 412(23–24):2046–2051.
|
| [16] |
Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection[J]. J Hepatol, 2008, 49(4):652–657.
|
| [17] |
Raimondo G, Caccamo G, Filomia R, et al. Occult HBV infection[J]. Semin Immunopathol, 2013, 35(1):39–52.
|
| [18] |
Raimondo G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection[J]. J Hepatol, 2007, 46(1):160–170.
|
| [19] |
Morales-Romero J, Vargas G, Garcia-Roman R. Occult HBV infection: a faceless enemy in liver cancer development[J]. Viruses, 2014, 6(4):1590–1611.
|
| [20] |
Taira R, Satake M, Momose S, et al. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan[J]. Transfusion, 2013, 53(7):1393–1404.
|
| [21] |
史德莹, 冬李, 汤晓雨, 等. 术前患者血清传染性指标和HBsAb检测结果分析[J]. 中国社区医师(医学专业), 2010, 35(12):166–167.
|
| [22] |
王凯. HBsAb免疫保护特性对降低HBV输血传染风险的作用[J]. 医药论坛杂志, 2013, 8:145–146.
|
| [23] |
赵磊. 探讨利用HBsAb免疫保护特性降低HBV输血传染风险[J]. 中国输血杂志, 2012, 25(Si):188.
|
| [24] |
Cheng L, Guan Q, Zhang J, et al. Discrepancies between two automated immunoassay systems in determining hepatitis B virus markers in serum samples with concomitant presence of antigens and antibodies[J]. Ann Clin Lab Sci, 2010, 40(1):49–52.
|
| [25] |
Zhang JM, Xu Y, Wang XY, et al. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection[J]. Clin Infect Dis, 2007, 44(9):1161–1169.
|
| [26] |
Protzer-Knolle U, Naumann U, Bartenschlager R, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation[J]. Hepatology, 1998, 27(1):254–263.
|
| [27] |
Hsu HY, Chang MH, Liaw SH, et al. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan[J]. Hepatology, 1999, 30(5):1312–1317.
|
| [28] |
Colson P, Borentain P, Motte A, et al. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers[J]. Virology, 2007, 367(1):30–40.
|
| [29] |
Zhang Z, Li L, Tian Y, et al. HBsAg/HBsAb double positive hepatitis B virus infection model in vitro and in vivo[J]. J Huazhong Univ Sci Technolog Med Sci, 2009, 29(5):575–579.
|
| [30] |
Seo SI, Choi HS, Choi BY, et al. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study[J]. J Med Virol, 2014, 86(1):124–130.
|
| [31] |
Laperche S, Nubling CM, Stramer SL, et al. Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples[J]. Transfusion, 2015, 55(10):2489–2499.
|
| [32] |
Wu S, Liu Y, Cheng L, et al. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China[J]. J Med Virol, 2011, 83(11):1930–1937.
|
| [33] |
Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep, 2003, 52(RR-3):1–13,5; quiz CE1–4.
|
| [34] |
CDC. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep, 2013, 62(18):362–365.
|
| [35] |
黄建生, 主编. 丙型肝炎[M]. 北京:人民军医出版社, 2013:306–352.
|
| [36] |
彭文伟, 主编. 传染病学[M]. 6版. 北京:人民卫生出版社, 2004:25.
|
| [37] |
Malm K, von Sydow M, Andersson S. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples[J]. Transfus Med, 2009, 19(2):78–88.
|
| [38] |
常俊峰. 三种HIV抗原／抗体检测方法对HIV早期感染检测的诊断研究[J]. 中国免疫学杂志, 2015, 31(8):1082–1084.
|
| [39] |
吉阳涛, 韩晓旭, 欧阳金鸣, 等. 三种四代HIV筛查试剂检测窗口期的差异研究[J]. 中华检验医学杂志, 2014, 37(8):613–616.
|
| [40] |
贾向东. 三种HIV抗体初筛方法的比较[J]. 临床输血与检验, 2010, 12(3):260.
|
| [41] |
李秀华, 许四宏, 宋爱京, 等. 4种国产和3种进口第4代HIV抗原抗体检测试剂的质量评价[J]. 中华微生物学和免疫学杂志, 2011, 31(9):847–850.
|
| [42] |
梅志锋, 朱晓华, 王剑甦. 三种HIV抗体初筛方法的比较[J]. 疾病监测与控制, 2011, 10(5):630–631.
|
| [43] |
欧阳金鸣, 韩晓旭, 吉阳涛, 等. 三种不同技术原理的第4代HIV诊断试剂的临床检测性能比较研究[J]. 中华检验医学杂志, 2013, 36(10):903–907.
|
| [44] |
性病与艾滋病中心. 二〇一三年全国艾滋病病毒抗体诊断试剂临床质量评估报告. 2013.
URL
|
| [45] |
杨坤, 淑燕, 黄新宝. ELISA 法与胶体金法检测血液抗-HIV 结果对比分析[J]. 医药前沿, 2012, 2(17):187–188.
|
| [46] |
朱柏林. 金标层析法与酶联免疫吸附试验初筛 HIV1+2型抗体对比分析[J]. 检验医学与临床, 2014, 11(10):1341–1346.
|
| [47] |
Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis[J]. J Eur Acad Dermatol Venereol, 2014, 28(12):1581–1593.
|
| [48] |
刘兵, 冯文莉. 梅毒实验室检测方法的研究进展[J]. 中国医药指南, 2015, 13(7):48–50.
|
| [49] |
文海燕, 张华荣, 陈正明, 等. 梅毒检测方法的研究进展[J]. 中国皮肤性病学杂志, 2012, 26(4):354–356,360.
|
| [50] |
魏万惠, 尹跃平, 王红春, 等. 2006-2008年全国梅毒血清学检测室间质评结果分析[J]. 中华皮肤科杂志, 2013, 46(5):353–355.
|